SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Credit Suisse Maintains Neutral on Regeneron Pharmaceuticals, Raises Price Target to $340

Credit Suisse maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Neutral and raises the price target from $310 to $340.

Benzinga · -

Credit Suisse maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Neutral and raises the price target from $310 to $340.